Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Pfizer Oncology - Building a new paradigm in prostate cancer

Expanding the potential of PARP inhibitors

Date

14 Sep 2020

Session

Pfizer Oncology - Building a new paradigm in prostate cancer

Presenters

Joaquin Mateo

Authors

J. Mateo

Author affiliations

Vall d'Hebron University Hospital, 8035 - Barcelona/ES

More

Resources

Login to access the resources on OncologyPRO.

Login

Resources from the same session

14 Sep 2020

Challenges in the treatment of prostate cancer

Presenter: Daniel George

Session: Pfizer Oncology - Building a new paradigm in prostate cancer

Resources:

Webcast

14 Sep 2020

Maximizing outcome with NHTs

Presenter: Arnulf Stenzl

Session: Pfizer Oncology - Building a new paradigm in prostate cancer

Resources:

Webcast

14 Sep 2020

Summary

Presenter: Daniel George

Session: Pfizer Oncology - Building a new paradigm in prostate cancer

Resources:

Webcast

14 Sep 2020

Live Q&A - 14 September 2020 - 15:30-16:00

Presenter: Daniel George

Session: Pfizer Oncology - Building a new paradigm in prostate cancer

Resources:

Webcast